Internal Medicine · North Miami Beach, FL
NPI
1790871481
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
100 NW 170th Street, Suite 208
North Miami Beach, FL, 33169
Phone (305) 405-0045
Groups this clinician bills Medicare through
Medicare paid, 2024
$19K
330 services
Medicare patients, 2024
43
Average age 62
Drug cost, 2024
$7.6M
10,167 prescriptions
Company payments, 2025
$748
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Deborah L Holmes was code 99214 (office e&m - established), 96 times for 35 patients. In total Deborah L Holmes billed 330 services in 27 codes, and Medicare paid $19K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 96 | 35 | $96.37 | $9,251 |
| 36415 Venipuncture Blood Collection | Office | 62 | 30 | $8.65 | $536 |
| 99213 Office E&M - Established | Office | 37 | 24 | $58.16 | $2,152 |
| 90480 Vaccine Administration | Office | 18 | 13 | $39.20 | $706 |
| 99215 Office E&M - Established | Office | 18 | 13 | $130.78 | $2,354 |
By year: 2022 $26K for 528 services; 2023 $18K for 308 services; 2024 $19K for 330 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 62 | 30 | $8.65 | $536 |
Medicare prescription drug claims, 2024
In 2024, the drug Deborah L Holmes prescribed most often to Medicare patients was Tivicay (Dolutegravir Sodium), with 463 prescriptions and refills. In total Deborah L Holmes wrote 10,167 Medicare prescriptions that cost $7.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tivicay Dolutegravir Sodium | 463 | 463 | 51 | $1.1M |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 393 | 393 | 48 | $1.5M |
| Amlodipine Besylate Generic | 392 | 564 | 59 | $1,073 |
| Atorvastatin Calcium Generic | 374 | 498 | 60 | $1,463 |
| Dovato Dolutegravir Sodium/Lamivudine | 354 | 354 | 36 | $1.0M |
| Juluca Dolutegravir/Rilpivirine | 289 | 289 | 29 | $986K |
| Gabapentin Generic | 270 | 302 | 44 | $3,056 |
| Metformin Hcl Generic | 237 | 329 | 34 | $1,032 |
| Zolpidem Tartrate Generic | 209 | 241 | 27 | $1,596 |
| Descovy Emtricitabine/Tenofov Alafenam | 178 | 178 | 20 | $392K |
| Hydrochlorothiazide Generic | 177 | 269 | 30 | $496 |
| Losartan Potassium Generic | 177 | 268 | 28 | $668 |
| Rosuvastatin Calcium Generic | 176 | 224 | 26 | $708 |
| Oxycodone Hcl Generic | 159 | 159 | 23 | $2,266 |
| Ritonavir Generic | 156 | 174 | 19 | $10K |
Brand drugs: 3,442 claims; generic drugs: 6,610 claims; opioid claims: 229.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Deborah L Holmes $748 ($748 in general payments such as food, travel and fees) from 7 companies. The largest payer was ViiV Healthcare Company with $517.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.